|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US6528067B1
(en)
|
1993-02-22 |
2003-03-04 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
BR9405798A
(pt)
|
1993-02-22 |
1995-12-12 |
Vivorx Pharmaceuticals Inc |
Métodos para liberação in vivo de material biológico e composições úteis dos mesmos
|
|
US5439686A
(en)
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US20030068362A1
(en)
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
|
US5362478A
(en)
|
1993-03-26 |
1994-11-08 |
Vivorx Pharmaceuticals, Inc. |
Magnetic resonance imaging with fluorocarbons encapsulated in a cross-linked polymeric shell
|
|
US6749868B1
(en)
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US5997904A
(en)
|
1993-02-22 |
1999-12-07 |
American Bioscience, Inc. |
Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof
|
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
US5650156A
(en)
|
1993-02-22 |
1997-07-22 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of nutriceuticals and compositions useful therefor
|
|
US6565842B1
(en)
|
1995-06-07 |
2003-05-20 |
American Bioscience, Inc. |
Crosslinkable polypeptide compositions
|
|
US20070092563A1
(en)
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
US20030199425A1
(en)
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
|
US8853260B2
(en)
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
NZ502500A
(en)
|
1997-06-27 |
2002-03-28 |
Vivorx Pharmaceuticals Inc |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
EP1171117A4
(en)
|
1999-04-22 |
2002-08-07 |
American Bioscience Inc |
LONG-TERM ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE AGENTS
|
|
AU784416B2
(en)
|
1999-05-21 |
2006-03-30 |
Abraxis Bioscience, Llc |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
|
ITMI20001107A1
(it)
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
|
ITMI20020681A1
(it)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina
|
|
SI1585548T1
(sl)
|
2002-12-09 |
2018-11-30 |
Abraxis Bioscience, Llc |
Sestave in metode odmerjanja farmakoloških sredstev
|
|
KR20110079741A
(ko)
|
2002-12-09 |
2011-07-07 |
아브락시스 바이오사이언스, 엘엘씨 |
약리학적 물질의 조성물 및 그 전달방법
|
|
AU2012201568B2
(en)
|
2005-02-18 |
2014-07-31 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
US20070166388A1
(en)
|
2005-02-18 |
2007-07-19 |
Desai Neil P |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
|
SI2301531T1
(sl)
|
2005-02-18 |
2018-11-30 |
Abraxis Bioscience, Llc |
Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija
|
|
RU2007144195A
(ru)
|
2005-04-29 |
2009-06-10 |
Козан Байосайенсиз Инкорпорейтед (Us) |
Способ лечения множественной миеломы с использованием 17-aag или 17-ag или пролекарства любого из них
|
|
CA2620389C
(en)
|
2005-08-31 |
2014-06-17 |
Abraxis Bioscience, Llc |
Compositions and methods for preparation of poorly water soluble drugs with increased stability
|
|
PL3311805T3
(pl)
|
2005-08-31 |
2020-07-27 |
Abraxis Bioscience, Llc |
Kompozycje zawierające słabo rozpuszczalne w wodzie środki farmaceutyczne i środki przeciwdrobnoustrojowe
|
|
JP2007297339A
(ja)
*
|
2006-04-29 |
2007-11-15 |
Torii Yakuhin Kk |
癌を治療又は検査するための医薬
|
|
CA2662140A1
(en)
|
2006-08-31 |
2008-03-06 |
Abraxis Bioscience, Llc |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
|
LT2117520T
(lt)
|
2006-12-14 |
2018-12-10 |
Abraxis Bioscience, Llc |
Krūties vėžio terapija hormonų receptoriaus statuso pagrindu su nanodalelėmis, apimančiomis taksaną
|
|
MX380318B
(es)
|
2007-03-07 |
2025-03-12 |
Abraxis Bioscience Llc |
Nanoparticula que comprende rapamicina y albumina como agente anticancer.
|
|
US20100166869A1
(en)
|
2007-05-03 |
2010-07-01 |
Desai Neil P |
Methods and compositions for treating pulmonary hypertension
|
|
AU2008260447B2
(en)
|
2007-06-01 |
2013-10-10 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
|
KR20100133475A
(ko)
|
2008-04-10 |
2010-12-21 |
아브락시스 바이오사이언스, 엘엘씨 |
소수성 탁산 유도체의 조성물 그의 용도
|
|
CA2721153C
(en)
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
|
JP5752592B2
(ja)
*
|
2008-04-11 |
2015-07-22 |
シアトル ジェネティックス， インコーポレイテッド |
膵臓癌、卵巣癌、および他の癌の検出および処置
|
|
NZ593343A
(en)
|
2008-12-11 |
2013-04-26 |
Abraxis Bioscience Llc |
Combination cancer treatment conprising Abraxane and an inflamatory inhibitor
|
|
GB0900555D0
(en)
|
2009-01-14 |
2009-02-11 |
Topotarget As |
New methods
|
|
KR101739598B1
(ko)
|
2009-03-13 |
2017-06-08 |
아브락시스 바이오사이언스, 엘엘씨 |
티오콜키신 유도체와의 조합 요법
|
|
AU2010233097B2
(en)
|
2009-04-10 |
2016-04-07 |
Abraxis Bioscience, Llc |
Nanoparticle formulations and uses thereof
|
|
KR20120044279A
(ko)
|
2009-04-15 |
2012-05-07 |
아브락시스 바이오사이언스, 엘엘씨 |
무-프리온 나노입자 조성물 및 방법
|
|
JP5886191B2
(ja)
*
|
2009-05-28 |
2016-03-16 |
アブラクシス バイオサイエンス， エルエルシー |
化学療法への反応を予測するための２つの抗ｓｐａｒｃ抗体の使用
|
|
SG10201609290PA
(en)
|
2009-08-25 |
2016-12-29 |
Abraxis Bioscience Llc |
Combination therapy with nanoparticle compositions of taxane and hedgehog inhibitors
|
|
JP2011079788A
(ja)
*
|
2009-10-08 |
2011-04-21 |
Oita Univ |
膵癌に対する選択的膵動脈制癌剤注入療法と全身化学療法との併用療法、およびそれに使用する膵癌治療薬
|
|
SG182367A1
(en)
*
|
2010-01-05 |
2012-08-30 |
Vascular Biogenics Ltd |
Methods for use of a specific anti-angiogenic adenoviral agent
|
|
BR112012024349A2
(pt)
|
2010-03-26 |
2016-05-24 |
Abraxis Bioscience Llc |
métodos de tratamento de carcinoma hepatocelular
|
|
RU2016119999A
(ru)
|
2010-03-29 |
2018-11-08 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Способы лечения онкологических заболеваний
|
|
CN105147613A
(zh)
|
2010-03-29 |
2015-12-16 |
阿布拉科斯生物科学有限公司 |
增强药物递送和治疗剂有效性的方法
|
|
WO2011121453A2
(en)
|
2010-03-30 |
2011-10-06 |
Clavis Pharma Asa |
Methods and compositions for treating or ameliorating cancer using gemcitabine-5'-elaidate
|
|
EP2575803B1
(en)
|
2010-06-02 |
2017-07-26 |
Abraxis BioScience, LLC |
Methods of treating bladder cancer
|
|
EP2575804A4
(en)
|
2010-06-04 |
2013-10-23 |
Abraxis Bioscience Llc |
METHOD FOR THE TREATMENT OF PANCREASCRE
|
|
US20140155344A1
(en)
|
2010-06-07 |
2014-06-05 |
Neil P. Desai |
Combination therapy methods for treating proliferative diseases
|
|
WO2012149451A1
(en)
|
2011-04-28 |
2012-11-01 |
Abraxis Bioscience, Llc |
Intravascular delivery of nanoparticle compositions and uses thereof
|
|
RU2705998C2
(ru)
|
2011-12-14 |
2019-11-13 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Применение полимерных эксципиентов для лиофилизации или заморозки частиц
|
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
US20140186447A1
(en)
|
2012-12-28 |
2014-07-03 |
Abraxis Bioscience, Llc |
Nanoparticle compositions of albumin and paclitaxel
|
|
US20140199404A1
(en)
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on level of a nucleoside transporter
|
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
|
US20140199405A1
(en)
|
2013-01-11 |
2014-07-17 |
Abraxis Bioscience, Llc |
Method for treating cancer based on mutation status of k-ras
|
|
WO2014123612A1
(en)
|
2013-02-11 |
2014-08-14 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
|
ES2804323T3
(es)
|
2013-03-12 |
2021-02-05 |
Abraxis Bioscience Llc |
Procedimientos de tratamiento de cáncer de pulmón
|
|
HK1219231A1
(zh)
|
2013-03-13 |
2017-03-31 |
阿布拉科斯生物科学有限公司 |
治疗儿童实体瘤的方法
|
|
CN105246468A
(zh)
|
2013-03-14 |
2016-01-13 |
阿布拉科斯生物科学有限公司 |
治疗膀胱癌的方法
|
|
US20170202782A1
(en)
|
2014-04-06 |
2017-07-20 |
Abraxis Bioscience, Llc |
Combination therapy comprising nanoparticles of a taxane and albumin with abt-263 in methods for treating cancer
|
|
WO2016141365A1
(en)
|
2015-03-05 |
2016-09-09 |
Abraxis Bioscience, Llc |
Method for treating cancer based on level of glucocorticoid receptor
|
|
NZ738929A
(en)
|
2015-06-29 |
2024-01-26 |
Abraxis Bioscience Llc |
Methods of treating solid tumors using nanoparticle mtor inhibitor combination therapy
|
|
MX2017016519A
(es)
|
2015-06-29 |
2018-08-16 |
Abraxis Bioscience Llc |
Biomarcadores para composiciones de nanoparticulas.
|
|
AU2016285720C1
(en)
|
2015-06-29 |
2022-02-03 |
Abraxis Bioscience, Llc |
Methods of treating epithelioid cell tumors
|
|
US20170181988A1
(en)
|
2015-12-23 |
2017-06-29 |
Cipla Limited |
Methods for the treatment of bladder cancer
|